Thursday, July 31, 2014 1:24:30 AM
What makes me believe that Titan is perhaps a little behind with their milestones isn’t what I’ve heard but rather the lack of what I’ve heard in my discussions. Lots of talk of optimization, not enough talk of filing the pre-submission package. I know that they’re working on it, it’s just a matter of timing. Conversely, when they file the pre-submission package they’ll have completed the design freeze at which point there’s no going back; that’s the model that will be used in clinical trials and deployed commercially. If they tweak anything else or find a way to cut costs, too bad – next generation. So, I do like the thought of them working on every detail and getting it all right. Weeks I can deal with if in fact that does turn out to be the case. I’m still optimistic this gets accomplished by the end of the year.
I’ll reiterate my take on Joe without really getting into it – I’m not concerned at all that Joe left. My understanding is that Joe didn’t do anything that others couldn’t, and were, doing themselves. At the end he was acting more as a liaison to Ximedica than utilizing his sales background in his role as VP Business Development. Whether or not that means that there’s also been a strategy shift with sales and marketing, that’s something that I’ve speculated on. I’ve mentioned that initially they may go with a 3rd party to handle the roll-out. To re-iterate, all speculation there, however it’s a thought that’s definitely crossed my mind.
I can’t give enough credit to IITF – he’s a real sleuth and has impeccable timing when it comes to new due diligence on Titan.
In terms of doing a press release, I can see the merit in it, however, as we’ve discussed in the past, management doesn’t necessarily. They’re (overly) paranoid about disclosing too much information, meanwhile, information such as the new patent is in the public realm, and very much searchable if you’re looking for it (which the competition certainly is), however, management doesn’t seem to appreciate the fact that retail investors don’t do such thorough due diligence (this board and it’s exemplary members are an exception to the rule), and don’t see value in press releasing something like this (or other events that our board has found significant but management hasn’t announced).
Re: the website, I’ve talked to multiple members of the Titan team about this and have stressed the importance of daily updates and professionalism. Yes, hopefully, the website is updated soon to reflect recent changes.
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM